Miren B Dhudasia1,2, Jonathan M Spergel3,4, Karen M Puopolo1,2,3, Corinna Koebnick5, Matthew Bryan6, Robert W Grundmeier3,7, Jeffrey S Gerber2,3,8, Scott A Lorch1,3, William O Quarshie7, Theoklis Zaoutis2,3, Sagori Mukhopadhyay9,2,3. 1. Divisions of Neonatology. 2. Center for Pediatric Clinical Effectiveness, and. 3. Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania Philadelphia, Pennsylvania. 4. Allergy-Immunology, and. 5. Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California; and. 6. Independent Statistician. 7. Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 8. Infectious Diseases. 9. Divisions of Neonatology, mukhopadhs@chop.edu.
Abstract
OBJECTIVES: To determine if maternal intrapartum group B Streptococcus (GBS) antibiotic prophylaxis is associated with increased risk of childhood asthma, eczema, food allergy, or allergic rhinitis. METHODS: Retrospective cohort study of 14 046 children. GBS prophylaxis was defined as administration of intravenous penicillin, ampicillin, cefazolin, clindamycin, or vancomycin to the mother, ≥4 hours before delivery. Composite primary outcome was asthma, eczema, or food allergy diagnosis within 5 years of age, identified by diagnosis codes and appropriate medication prescription. Allergic rhinitis was defined by using diagnostic codes only and analyzed as a separate outcome. Analysis was a priori stratified by delivery mode and conducted by using Cox proportional hazards model adjusted for multiple confounders and covariates. Secondary analyses, restricted to children retained in cohort at 5 years' age, were conducted by using multivariate logistic regression. RESULTS: GBS prophylaxis was not associated with increased incidence of composite outcome among infants delivered vaginally (hazard ratio: 1.13, 95% confidence interval [CI]: 0.95-1.33) or by cesarean delivery (hazard ratio: 1.08, 95% CI: 0.88-1.32). At 5 years of age, among 10 404 children retained in the study, GBS prophylaxis was not associated with the composite outcome in vaginal (odds ratio: 1.21, 95% CI: 0.96-1.52) or cesarean delivery (odds ratio: 1.17, 95% CI: 0.88-1.56) cohorts. Outcomes of asthma, eczema, food allergy, separately, and allergic rhinitis were also not associated with GBS prophylaxis. CONCLUSIONS: Intrapartum GBS prophylaxis was not associated with subsequent diagnosis of asthma, eczema, food allergy, or allergic rhinitis in the first 5 years of age.
OBJECTIVES: To determine if maternal intrapartum group B Streptococcus (GBS) antibiotic prophylaxis is associated with increased risk of childhood asthma, eczema, food allergy, or allergic rhinitis. METHODS: Retrospective cohort study of 14 046 children. GBS prophylaxis was defined as administration of intravenous penicillin, ampicillin, cefazolin, clindamycin, or vancomycin to the mother, ≥4 hours before delivery. Composite primary outcome was asthma, eczema, or food allergy diagnosis within 5 years of age, identified by diagnosis codes and appropriate medication prescription. Allergic rhinitis was defined by using diagnostic codes only and analyzed as a separate outcome. Analysis was a priori stratified by delivery mode and conducted by using Cox proportional hazards model adjusted for multiple confounders and covariates. Secondary analyses, restricted to children retained in cohort at 5 years' age, were conducted by using multivariate logistic regression. RESULTS: GBS prophylaxis was not associated with increased incidence of composite outcome among infants delivered vaginally (hazard ratio: 1.13, 95% confidence interval [CI]: 0.95-1.33) or by cesarean delivery (hazard ratio: 1.08, 95% CI: 0.88-1.32). At 5 years of age, among 10 404 children retained in the study, GBS prophylaxis was not associated with the composite outcome in vaginal (odds ratio: 1.21, 95% CI: 0.96-1.52) or cesarean delivery (odds ratio: 1.17, 95% CI: 0.88-1.56) cohorts. Outcomes of asthma, eczema, food allergy, separately, and allergic rhinitis were also not associated with GBS prophylaxis. CONCLUSIONS: Intrapartum GBS prophylaxis was not associated with subsequent diagnosis of asthma, eczema, food allergy, or allergic rhinitis in the first 5 years of age.
Authors: Darios Getahun; Daniel Strickland; Robert S Zeiger; Michael J Fassett; Wansu Chen; George G Rhoads; Steven J Jacobsen Journal: Arch Pediatr Adolesc Med Date: 2010-02
Authors: C Roduit; S Scholtens; J C de Jongste; A H Wijga; J Gerritsen; D S Postma; B Brunekreef; M O Hoekstra; R Aalberse; H A Smit Journal: Thorax Date: 2008-12-03 Impact factor: 9.139
Authors: Stephanie J Schrag; Elizabeth R Zell; Ruth Lynfield; Aaron Roome; Kathryn E Arnold; Allen S Craig; Lee H Harrison; Arthur Reingold; Karen Stefonek; Glenda Smith; Melanie Gamble; Anne Schuchat Journal: N Engl J Med Date: 2002-07-25 Impact factor: 91.245
Authors: Yan Shao; Samuel C Forster; Evdokia Tsaliki; Kevin Vervier; Angela Strang; Nandi Simpson; Nitin Kumar; Mark D Stares; Alison Rodger; Peter Brocklehurst; Nigel Field; Trevor D Lawley Journal: Nature Date: 2019-09-18 Impact factor: 49.962
Authors: Johanna Metsälä; Annamari Lundqvist; Lauri J Virta; Minna Kaila; Mika Gissler; Suvi M Virtanen Journal: Epidemiology Date: 2013-03 Impact factor: 4.822
Authors: Roosa Jokela; Katri Korpela; Ching Jian; Evgenia Dikareva; Anne Nikkonen; Terhi Saisto; Kirsi Skogberg; Willem M de Vos; Kaija-Leena Kolho; Anne Salonen Journal: Gut Microbes Date: 2022 Jan-Dec